The Genomic Medicine Alliance is an international research network with research activities that focus on Genomic Medicine. In 2016, the Genomic Medicine Alliance has over 1100 members from various countries from all over the world.

The Genomic Medicine Alliance aims to create collaboration ties between academics, researchers, regulators, and the general public interested in all aspects of genomics and personalized medicine. The Alliance provides the means to establish networks and to encourage collaborative work towards advancing the Genomic Medicine discipline, focusing in particular on translating results from academic research into clinical practice.

In particular, the Genomic Medicine Alliance aims to:

  • Encourage and catalyze multidisciplinary collaborative research between partner institutions and scientists, particularly from emerging countries.
  • Liaise among research organizations, clinical entities and regulatory agencies in areas related to genomic medicine.
  • Facilitate the introduction of pharmacogenomics and advanced omics technologies into the mainstream clinical practice.
  • Produce and propose guidelines and recommendations in all areas pertaining to genomic medicine, always in close collaboration with other scientific academic entities, agencies and regulatory bodies.
  • Develop, independently or in close collaboration with partner institutions, and coordinate educational activities in the area of genomic medicine.


You can find us


145 -157 St John Street, London, EC1V 4PW, UK

Tel: +44-(0)207-608.51.91,
E-mail: gma(AT)goldenhelix{DOT}org